Education
About Us
Working with TipRanks
Follow Us
Catherine Sohn Insider Profile
11 Followers
Catherine Sohn, Director at Jazz Pharmaceuticals, holds 1.00K shares in Altimmune (Ticker: ALT), holds 14.87K shares in Jazz Pharmaceuticals (Ticker: JAZZ), holds 54.07K shares in Lifecore Biomedical (Ticker: LFCR). Most recently, Catherine Sohn Bought ― shares of Altimmune on Mar 18, 2025 for an estimated value of $5.78K.
Profitable Transactions
9 out of 17 Profitable Transactions
Average Return
-0.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Catherine Sohn holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jun 10, 2014 - Jun 10, 2015
Return:+26.90%
The most profitable trade made by Catherine Sohn
Catherine Sohn's Trading History
Jazz Pharmaceuticals
Aug 15, 2023
Director
Uninformative Buy
―
$2.10M
Rubius Therapeutics
Jul 23, 2018
―
Informative Buy
57.50K
$142.50
Axcella Health
Jan 21, 2020
―
Informative Buy
4.87K
$400.00
Altimmune
Mar 18, 2025
Director
Informative Buy
5.78K
$4.17K
Maze Therapeutics, Inc.
―
Director
―
―
Palisade Bio
Jul 06, 2015
Director
Uninformative Buy
―
$228.88K
Lifecore Biomedical
Jun 07, 2022
Director
Uninformative Buy
67.06K
$430.39K
List of latest transactions for each holding click on a transaction to see Catherine Sohn's performance on stock
You May Also Like
Catherine Sohn insider profile FAQ
What is the percentage of profitable transactions made by Catherine Sohn?
The percentage of profitable transactions made by Catherine Sohn is 53%.
What is the average return per transaction made by Catherine Sohn?
The average return per transaction made by Catherine Sohn is -0.40%.
What stocks does Catherine Sohn hold?
Catherine Sohn holds: JAZZ, RUBY, AXLA, ALT, MAZE, PALI, LFCR stocks.
What was Catherine Sohn’s latest transaction?
Catherine Sohn latest transaction was an Informative Buy of $5.78K.
What was Catherine Sohn's most profitable transaction?
Catherine Sohn’s most profitable transaction was an Informative Buy of LFCR stock on June 10, 2014. The return on the trade was 26.90%.
What is Catherine Sohn's role in Jazz Pharmaceuticals?
Catherine Sohn's role in Jazz Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.